Align 3-phosphoshikimate 1-carboxyvinyltransferase (EC 2.5.1.19) (characterized)
to candidate WP_012384618.1 BIND_RS08260 3-phosphoshikimate 1-carboxyvinyltransferase
Query= BRENDA::A1Z0H6 (444 letters) >NCBI__GCF_000019845.1:WP_012384618.1 Length = 424 Score = 512 bits (1318), Expect = e-149 Identities = 260/408 (63%), Positives = 303/408 (74%) Query: 35 VTPPNFPLTGKVAPPGSKSITNRALLLAALAKGTSRLSGALKSDDTRHMSVALRQMGVTI 94 ++PP PL G + PPGSKSITNRALLLAALAKG SRL+GAL SDDT +M+ AL+ MGV I Sbjct: 13 LSPPGQPLQGHIRPPGSKSITNRALLLAALAKGESRLTGALASDDTAYMAKALKAMGVGI 72 Query: 95 DEPDDTTFVVTSQGSLQLPAQPLFLGNAGTAMRFLTAAVATVQGTVVLDGDEYMQKRPIG 154 + PD TTF V G L P + LFLGNAGTA RFLTAA A G VV+DGD M+KRPI Sbjct: 73 ESPDATTFHVKGTGHLHAPGETLFLGNAGTATRFLTAAAALADGRVVIDGDANMRKRPIA 132 Query: 155 PLLATLGQNGIQVDSPTGCPPVTVHGMGKVQAKRFEIDGGLSSQYVSALLMLAACGEAPI 214 PL+ L G+ +++PTGCPPVT+ G G+V A ID GLSSQYVSALLMLA CGE PI Sbjct: 133 PLVTALQSLGVSIEAPTGCPPVTIDGRGRVAAGDVSIDAGLSSQYVSALLMLAPCGEGPI 192 Query: 215 EVALTGKDIGARGYVDLTLDCMRAFGAQVDAVDDTTWRVAPTGYTAHDYLIEPDASAATY 274 + L G IGARGYVDLTL M FGA+V D+ +W +APTGY A D++IEPDASAATY Sbjct: 193 RIVLQGTGIGARGYVDLTLAAMHHFGAEVLQKDEVSWTLAPTGYRARDFVIEPDASAATY 252 Query: 275 LWAAEVLTGGRIDIGVAAQDFTQPDAKAQAVIAQFPNMQATVVGSQMQDAIPTLAVLAAF 334 LWAA VLT G ID+GV A FTQPDAKA ++I FP+M A + GSQ+QDA+PTLAV+AAF Sbjct: 253 LWAAAVLTQGTIDLGVPASAFTQPDAKAYSLITSFPHMPAVIEGSQIQDAVPTLAVMAAF 312 Query: 335 NNTPVRFTELANLRVKECDRVQALHDGLNEIRPGLATIEGDDLLVASDPALAGTACTALI 394 N TPVRFT++ANLRVKECDR+ AL L I P LA EGDDL+V DPAL G A+I Sbjct: 313 NKTPVRFTDIANLRVKECDRIHALATELARITPDLAREEGDDLIVTGDPALIGRRTDAII 372 Query: 395 DTHADHRIAMCFALAGLKVSGVRIQDPDCVAKTYPDYWKAWPSLGVHL 442 +T+ DHRIAM FALAGL + G+ I DPDCVAKTYP +W SLGV L Sbjct: 373 ETYDDHRIAMSFALAGLMMDGLTILDPDCVAKTYPGFWNDLGSLGVRL 420 Lambda K H 0.318 0.134 0.400 Gapped Lambda K H 0.267 0.0410 0.140 Matrix: BLOSUM62 Gap Penalties: Existence: 11, Extension: 1 Number of Sequences: 1 Number of Hits to DB: 620 Number of extensions: 17 Number of successful extensions: 2 Number of sequences better than 1.0e-02: 1 Number of HSP's gapped: 1 Number of HSP's successfully gapped: 1 Length of query: 444 Length of database: 424 Length adjustment: 32 Effective length of query: 412 Effective length of database: 392 Effective search space: 161504 Effective search space used: 161504 Neighboring words threshold: 11 Window for multiple hits: 40 X1: 16 ( 7.3 bits) X2: 38 (14.6 bits) X3: 64 (24.7 bits) S1: 41 (21.7 bits) S2: 51 (24.3 bits)
Align candidate WP_012384618.1 BIND_RS08260 (3-phosphoshikimate 1-carboxyvinyltransferase)
to HMM TIGR01356 (aroA: 3-phosphoshikimate 1-carboxyvinyltransferase (EC 2.5.1.19))
# hmmsearch :: search profile(s) against a sequence database # HMMER 3.3.1 (Jul 2020); http://hmmer.org/ # Copyright (C) 2020 Howard Hughes Medical Institute. # Freely distributed under the BSD open source license. # - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - # query HMM file: ../tmp/path.aa/TIGR01356.hmm # target sequence database: /tmp/gapView.3565.genome.faa # - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - Query: TIGR01356 [M=415] Accession: TIGR01356 Description: aroA: 3-phosphoshikimate 1-carboxyvinyltransferase Scores for complete sequences (score includes all domains): --- full sequence --- --- best 1 domain --- -#dom- E-value score bias E-value score bias exp N Sequence Description ------- ------ ----- ------- ------ ----- ---- -- -------- ----------- 1.5e-109 352.5 0.0 6.8e-107 343.7 0.0 2.0 1 lcl|NCBI__GCF_000019845.1:WP_012384618.1 BIND_RS08260 3-phosphoshikimate Domain annotation for each sequence (and alignments): >> lcl|NCBI__GCF_000019845.1:WP_012384618.1 BIND_RS08260 3-phosphoshikimate 1-carboxyvinyltransferase # score bias c-Evalue i-Evalue hmmfrom hmm to alifrom ali to envfrom env to acc --- ------ ----- --------- --------- ------- ------- ------- ------- ------- ------- ---- 1 ! 343.7 0.0 6.8e-107 6.8e-107 1 413 [. 22 417 .. 22 419 .. 0.93 Alignments for each domain: == domain 1 score: 343.7 bits; conditional E-value: 6.8e-107 TIGR01356 1 geikipgsKSishRalllaaLaegetvvtnlLkseDtlatlealrklGakve.eekeelviegvgglke 68 g+i+ pgsKSi++RalllaaLa+ge+++t+ L s+Dt ++ +al+++G+ +e + +++++g g l+ lcl|NCBI__GCF_000019845.1:WP_012384618.1 22 GHIRPPGSKSITNRALLLAALAKGESRLTGALASDDTAYMAKALKAMGVGIEsPDATTFHVKGTGHLHA 90 789*************************************************55599*******99*** PP TIGR01356 69 peaeldlgnsGttaRlltgvlalasgevvltgdeslkkRPierlveaLrelgaeieskeeegslPlais 137 p ++l lgn+Gt++R+lt+++ala+g vv++gd ++kRPi +lv+aL++lg++ie+ + g++P++i+ lcl|NCBI__GCF_000019845.1:WP_012384618.1 91 PGETLFLGNAGTATRFLTAAAALADGRVVIDGDANMRKRPIAPLVTALQSLGVSIEAPT--GCPPVTID 157 ********************************************************977..8******* PP TIGR01356 138 gp..lkggivelsgsaSsQyksalllaaplalqavtleivgeklisrpyieitLkllksfgveveeede 204 g + +g v +++ SsQy+sall++ap + + + ++g+ + r y+++tL+ +++fg ev ++de lcl|NCBI__GCF_000019845.1:WP_012384618.1 158 GRgrVAAGDVSIDAGLSSQYVSALLMLAPCGEGPIRIVLQGTGIGARGYVDLTLAAMHHFGAEVLQKDE 226 *986666************************************************************** PP TIGR01356 205 rkivvkggqkykqkevevegDaSsAafflaaaaitgeevtvenlgenstqgdkaiiivLeemGadveve 273 ++++ +++ y+ +++ +e DaS+A+++ aaa++t++++ + ++ tq+d+++ + lcl|NCBI__GCF_000019845.1:WP_012384618.1 227 VSWTLAPTG-YRARDFVIEPDASAATYLWAAAVLTQGTIDLGVPASAFTQPDAKAYS------------ 282 999999987.99999***************************99********43333............ PP TIGR01356 274 eqrdvevegasklkgvkvdidvdsliDelptlavlaafAegetriknieelRvkEsdRiaaiaeeLekl 342 +++ ++ + i+ +++ D++ptlav+aaf +++ r ++i++lRvkE+dRi+a+a+eL+++ lcl|NCBI__GCF_000019845.1:WP_012384618.1 283 ----LITS-FPHM-PAV--IEGSQIQDAVPTLAVMAAFNKTPVRFTDIANLRVKECDRIHALATELARI 343 ....3333.2334.455..7889999******************************************* PP TIGR01356 343 Gve.veeledgllieGkk...kelkgavvdtydDHRiamalavlglaaegeveiedaecvaksfPeFfe 407 + ++e d l+++G + +a ++tydDHRiam++a++gl ++ +++i d+ cvak++P F++ lcl|NCBI__GCF_000019845.1:WP_012384618.1 344 TPDlAREEGDDLIVTGDPaliGRRTDAIIETYDDHRIAMSFALAGLMMD-GLTILDPDCVAKTYPGFWN 411 9983578889*******9777777779*********************9.******************* PP TIGR01356 408 vleqlg 413 +l +lg lcl|NCBI__GCF_000019845.1:WP_012384618.1 412 DLGSLG 417 *99886 PP Internal pipeline statistics summary: ------------------------------------- Query model(s): 1 (415 nodes) Target sequences: 1 (424 residues searched) Passed MSV filter: 1 (1); expected 0.0 (0.02) Passed bias filter: 1 (1); expected 0.0 (0.02) Passed Vit filter: 1 (1); expected 0.0 (0.001) Passed Fwd filter: 1 (1); expected 0.0 (1e-05) Initial search space (Z): 1 [actual number of targets] Domain search space (domZ): 1 [number of targets reported over threshold] # CPU time: 0.06u 0.01s 00:00:00.06 Elapsed: 00:00:00.06 # Mc/sec: 2.86 // [ok]
This GapMind analysis is from Apr 10 2024. The underlying query database was built on Apr 09 2024.
Each pathway is defined by a set of rules based on individual steps or genes. Candidates for each step are identified by using ublast (a fast alternative to protein BLAST) against a database of manually-curated proteins (most of which are experimentally characterized) or by using HMMer with enzyme models (usually from TIGRFam). Ublast hits may be split across two different proteins.
A candidate for a step is "high confidence" if either:
Otherwise, a candidate is "medium confidence" if either:
Other blast hits with at least 50% coverage are "low confidence."
Steps with no high- or medium-confidence candidates may be considered "gaps." For the typical bacterium that can make all 20 amino acids, there are 1-2 gaps in amino acid biosynthesis pathways. For diverse bacteria and archaea that can utilize a carbon source, there is a complete high-confidence catabolic pathway (including a transporter) just 38% of the time, and there is a complete medium-confidence pathway 63% of the time. Gaps may be due to:
GapMind relies on the predicted proteins in the genome and does not search the six-frame translation. In most cases, you can search the six-frame translation by clicking on links to Curated BLAST for each step definition (in the per-step page).
For more information, see:
If you notice any errors or omissions in the step descriptions, or any questionable results, please let us know
by Morgan Price, Arkin group, Lawrence Berkeley National Laboratory